STOCKHOLM, Sweden--(BUSINESS WIRE)--Q-Med AB and Medy-Tox Inc. have today signed an agreement for the exclusive distribution of Medy-Tox Botulinum Toxin type A product in Europe, excluding Russia, and non-exclusive distribution of the product in Japan.
